|
Product class:
|
Authorized package
|
|
Medicinal product class:
|
For human use
|
|
Package code:
|
1395356
|
|
Name of medicinal product:
|
ALLI
|
|
Active substances:
|
|
|
ATC code:
|
A08AB01
|
|
Dosage form:
|
capsule, hard
|
|
Route of administration:
|
oral use
|
|
Strengh:
|
60mg
|
|
Amount in package:
|
60TK
|
|
Legal status for supply*:
|
Not subject to medicinal prescription
|
|
Class of active substance:
|
|
|
Additional information:
|
|
|
Indication:
|
alli is indicated for weight loss in adults who are overweight (body mass index, BMI, >_28 kg/m2) and should be taken in conjunction with a mildly hypocaloric, lower-fat diet.
|
|
Safety features:
|
No
|
|
Summary of product characteristics (SPC):
|
|
|
Package information leaflet (PIL):
|
EST
|
|
Labelling:
|
|
|
Last imported to Estonia:
|
Never imported to Estonia
|
|
Marketing authorization holder:
|
GlaxoSmithKline Dungarvan Limited
|
|
Marketing authorization number:
|
EU/1/07/401
|
|
Marketing authorization issued on:
|
July 25, 2012
|
|
Marketing authorization expires on:
|
Unlimited
|
|
Marketing authorization procedure type:
|
Centralised
|
|
Reference price:
|
|
|
Under reference price:
|
|
|
Reference price of daily dose:
|
|
Entry/Changing date:
November 26, 2018
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere